Lv5
920 积分 2022-09-13 加入
The Safety and Efficacy of Weekly Paclitaxel Administration for Anaplastic Thyroid Cancer Patients: A Nationwide Prospective Study
1天前
待确认
Adjuvant Pembrolizumab after Upfront Multimodal Therapy for Stage IVB Anaplastic Thyroid Cancer
1天前
待确认
Dual Immune Checkpoint Inhibition in Patients With Aggressive Thyroid Carcinoma
1天前
待确认
PD-1 Blockade in Anaplastic Thyroid Carcinoma
1天前
待确认
Phase II study of the efficacy and safety of lenvatinib for anaplastic thyroid cancer (HOPE)
1天前
待确认
Lenvatinib plus pembrolizumab for the Treatment of Patients With Non-BRAF mutated Anaplastic Thyroid Cancer: A single center, phase 2 clinical trial
1天前
待确认
Multidisciplinary expert consensus on diagnosis and treatment of multiple lung cancers
2个月前
已完结
Survival outcomes and response to immune checkpoint inhibitors among patients with advanced Merkel cell carcinoma: a retrospective study of 81 patients
3个月前
已完结
Phase II study of retifanlimab in patients with recurrent locally advanced or metastatic Merkel cell carcinoma (POD1UM-201)
3个月前
已完结
Differences in survival improvement between known and unknown primary Merkel cell carcinoma in the era of immune checkpoint inhibitors
3个月前
已完结
皖公网安备34019202002308
